Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.110
-0.020 (-1.77%)
Dec 5, 2025, 4:00 PM EST - Market closed
Company Description
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis.
Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Tenon Medical, Inc.
| Country | United States |
| Founded | 2012 |
| IPO Date | Apr 27, 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Steven Foster |
Contact Details
Address: 104 Cooper Court Los Gatos, California 95032 United States | |
| Phone | 408-649-5760 |
| Website | tenonmed.com |
Stock Details
| Ticker Symbol | TNON |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001560293 |
| CUSIP Number | 88066N303 |
| ISIN Number | US88066N3035 |
| Employer ID | 45-5574718 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Foster | Chief Executive Officer, President and Director |
| Richard Ginn | Founder, Chief Technology Officer, Chief Operating Officer and Director |
| Kevin Williamson | Chief Financial Officer |
| Richard M. Ferrari | Founder and Executive Chairman |
| Steve Moscaret | General Manager of Marketing and Sales Operation |
| Nathaniel A. Grawey | Chief Commercial Officer |
| Wyatt Giest | Chief Innovation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 25, 2025 | D | Notice of Exempt Offering of Securities |
| Nov 17, 2025 | 8-K | Current Report |
| Nov 13, 2025 | 10-Q | Quarterly Report |
| Oct 17, 2025 | 8-K/A | [Amend] Current report |
| Oct 16, 2025 | 8-K | Current Report |
| Oct 10, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Sep 23, 2025 | 8-K | Current Report |
| Sep 18, 2025 | DEFR14A | Filing |
| Aug 13, 2025 | 10-Q | Quarterly Report |
| Aug 8, 2025 | SCHEDULE 13D | Filing |